Medscape BOSTON, MA ( updated ) — Authors of a new meta-analysis comparing a bivalirudin (Angiomax, the Medicines Company)-based regimen vs a heparin -based approach in...
FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
Scientific American For the past 20 years pregnant women with an increased risk of developing blood clots have often been prescribed a common blood thinner to prevent se...
Healthcare Packaging Biologic drugs are not a new concept—legacy biologics such as heparin , insulin, and some vaccines have been available for therapeutic use for some time. However, more modern biologics—including monoclonal antibodies, protein therapies and cell- and ...
Healio In a pooled analysis of the HORIZONS-AMI and EUROMAX trials, primary PCI with bivalirudin was associated with improved net 30-day clinical outcomes and transfusions, but a higher rate of acute stent thrombosis, compared with unfractionated heparin plus ... and more »
